KORU Medical Systems annual net profit margin
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
KORU Medical Systems Net Profit Margin Growth & History (KRMD)
KORU Medical Systems's net profit margin was −6.41% for fiscal 2025.
View full KORU Medical Systems company overviewKORU Medical Systems annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −6.41% | +11.62 pp |
| 2024 | 2024-12-31 | −18.03% | +30.15 pp |
| 2023 | 2023-12-31 | −48.18% | −17.14 pp |
| 2022 | 2022-12-31 | −31.05% | −11.62 pp |
| 2021 | 2021-12-31 | −19.42% | −14.41 pp |
| 2020 | 2020-12-31 | −5.01% | −7.45 pp |
| 2019 | 2019-12-31 | 2.44% | −2.81 pp |
| 2018 | 2018-12-31 | 5.25% | −1.55 pp |
| 2017 | 2017-12-31 | 6.80% | — |
| 2016 | 2017-02-28 | −4.35% | −10.74 pp |
| 2015 | 2016-02-29 | 6.39% | −0.31 pp |
| 2014 | 2015-02-28 | 6.70% | −1.39 pp |
| 2013 | 2014-02-28 | 8.09% | −1.26 pp |
| 2012 | 2013-02-28 | 9.35% | −3.42 pp |
| 2011 | 2012-02-29 | 12.77% | −1.54 pp |
| 2010 | 2011-02-28 | 14.31% | — |
KORU Medical Systems quarterly net profit margin
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q1.16
Q2.16
Q2.16
Q3.16
Q1.17
Q1.17
Q2.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 2.10% | +4.12 pp |
| Q1 2026 | 2026-03-31 | −6.86% | +5.24 pp |
| Q4 2025 | 2025-12-31 | −4.47% | +13.19 pp |
| Q3 2025 | 2025-09-30 | −7.48% | +11.85 pp |
| Q2 2025 | 2025-06-30 | −2.03% | +9.70 pp |
| Q1 2025 | 2025-03-31 | −12.10% | +11.51 pp |
| Q4 2024 | 2024-12-31 | −17.66% | +86.24 pp |
| Q3 2024 | 2024-09-30 | −19.33% | +0.21 pp |
| Q2 2024 | 2024-06-30 | −11.73% | +24.26 pp |
| Q1 2024 | 2024-03-31 | −23.62% | +9.00 pp |
| Q4 2023 | 2023-12-31 | −103.90% | −76.98 pp |
| Q3 2023 | 2023-09-30 | −19.54% | −3.75 pp |
| Q2 2023 | 2023-06-30 | −35.98% | +8.64 pp |
| Q1 2023 | 2023-03-31 | −32.61% | +8.02 pp |
| Q4 2022 | 2022-12-31 | −26.91% | −10.45 pp |
| Q3 2022 | 2022-09-30 | −15.79% | +2.31 pp |
| Q2 2022 | 2022-06-30 | −44.62% | −24.28 pp |
| Q1 2022 | 2022-03-31 | −40.64% | −17.14 pp |
| Q4 2021 | 2021-12-31 | −16.46% | +4.11 pp |
| Q3 2021 | 2021-09-30 | −18.11% | −22.21 pp |
| Q2 2021 | 2021-06-30 | −20.34% | −6.38 pp |
| Q1 2021 | 2021-03-31 | −23.50% | −30.60 pp |
| Q4 2020 | 2020-12-31 | −20.57% | −19.28 pp |
| Q3 2020 | 2020-09-30 | 4.10% | −5.75 pp |
| Q2 2020 | 2020-06-30 | −13.96% | −15.42 pp |
| Q1 2020 | 2020-03-31 | 7.10% | +8.82 pp |
| Q4 2019 | 2019-12-31 | −1.29% | +7.03 pp |
| Q3 2019 | 2019-09-30 | 9.85% | +1.35 pp |
| Q2 2019 | 2019-06-30 | 1.46% | −9.10 pp |
| Q1 2019 | 2019-03-31 | −1.72% | −11.72 pp |
| Q4 2018 | 2018-12-31 | −8.31% | −26.53 pp |
| Q3 2018 | 2018-09-30 | 8.50% | +1.60 pp |
| Q2 2018 | 2018-06-30 | 10.57% | +6.69 pp |
| Q1 2018 | 2018-03-31 | 10.00% | +6.51 pp |
| Q4 2017 | 2017-12-31 | 18.22% | — |
| Q2 2017 | 2017-09-30 | 6.90% | +11.66 pp |
| Q1 2017 · Jun 30 | 2017-06-30 | 3.88% | +15.33 pp |
| Q1 2017 · Mar 31 | 2017-03-31 | 3.49% | — |
| Q3 2016 | 2016-11-30 | −3.27% | −8.59 pp |
| Q2 2016 · Sep 30 | 2016-09-30 | −4.76% | — |
| Q2 2016 · Aug 31 | 2016-08-31 | −2.62% | −13.21 pp |
| Q1 2016 · Jun 30 | 2016-06-30 | −11.45% | — |
| Q1 2016 · May 31 | 2016-05-31 | −7.80% | −5.35 pp |
| Q4 2015 | 2016-02-29 | 10.43% | +1.75 pp |
| Q3 2015 | 2015-11-30 | 5.33% | +1.84 pp |
| Q2 2015 | 2015-08-31 | 10.59% | +2.48 pp |
| Q1 2015 | 2015-05-31 | −2.46% | −8.45 pp |
| Q4 2014 | 2015-02-28 | 8.68% | −5.64 pp |
| Q3 2014 | 2014-11-30 | 3.49% | −3.94 pp |
| Q2 2014 | 2014-08-31 | 8.10% | +3.59 pp |
| Q1 2014 | 2014-05-31 | 5.99% | +2.08 pp |
| Q4 2013 | 2014-02-28 | 14.33% | +2.85 pp |
| Q3 2013 | 2013-11-30 | 7.43% | +4.75 pp |
| Q2 2013 | 2013-08-31 | 4.52% | −13.45 pp |
| Q1 2013 | 2013-05-31 | 3.91% | −1.27 pp |
| Q4 2012 | 2013-02-28 | 11.48% | −4.15 pp |
| Q3 2012 | 2012-11-30 | 2.68% | −9.46 pp |
| Q2 2012 | 2012-08-31 | 17.97% | +9.30 pp |
| Q1 2012 | 2012-05-31 | 5.18% | −8.07 pp |
| Q4 2011 | 2012-02-29 | 15.62% | — |
| Q3 2011 | 2011-11-30 | 12.14% | −1.27 pp |
| Q2 2011 | 2011-08-31 | 8.67% | −0.71 pp |
| Q1 2011 | 2011-05-31 | 13.25% | — |
| Q3 2010 | 2010-11-30 | 13.41% | — |
| Q2 2010 | 2010-08-31 | 9.38% | — |
KORU Medical Systems net profit margin trends
Over the last five fiscal years, KORU Medical Systems's net profit margin decreased from −5.01% to −6.41%, a change of −1.40 percentage points. The latest reported quarter, Q2 2026, shows 2.10%.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review KORU Medical Systems source filings ↗